(Q43832976)

English

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study (English)

1 reference

Europe PubMed Central

27 November 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

G Walldius

1

1 reference

Europe PubMed Central

27 November 2017

I Jungner

2

1 reference

Europe PubMed Central

27 November 2017

I Holme

3

1 reference

Europe PubMed Central

27 November 2017

A H Aastveit

4

1 reference

Europe PubMed Central

27 November 2017

W Kolar

5

1 reference

Europe PubMed Central

27 November 2017

E Steiner

6

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

358

1 reference

Europe PubMed Central

27 November 2017

2026-2033

1 reference

Europe PubMed Central

27 November 2017

9298

1 reference

Europe PubMed Central

27 November 2017

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between HDL-cholesterol and apolipoprotein A1 and the severity of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombogenic factors and recurrent coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

LDL size and risk of coronary heart disease in elderly men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherogenicity of triglyceride-rich lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Apolipoprotein concentrations during treatment and recurrent coronary artery disease events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of dyslipidemia: room for improvement?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2907098-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(01)07098-2

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43832976&oldid=2103737031"